STOML2 and laryngeal squamous cell carcinoma: STOML2 has been described as a positive regulator of cancer cell growth; its increased expression is associated with esophageal precancers and its expression has been reported as increasing with invasive disease stages in laryngeal squamous cell carcinomas 24,26.